Skip to content
LexBuild

Manufacturer of Controlled Substances Application: MALLINCKRODT, LLC; Correction

---
identifier: "/us/fr/2015-13835"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Manufacturer of Controlled Substances Application: MALLINCKRODT, LLC; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2015-13835"
section_name: "Manufacturer of Controlled Substances Application: MALLINCKRODT, LLC; Correction"
positive_law: false
currency: "2015-06-08"
last_updated: "2015-06-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2015-13835"
document_type: "notice"
publication_date: "2015-06-08"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "80 FR 32411"
fr_volume: 80
docket_ids:
  - "Docket No. DEA-392"
fr_action: "Notice of application; correction."
---

#  Manufacturer of Controlled Substances Application: MALLINCKRODT, LLC; Correction

**ACTION:**

Notice of application; correction.

**SUMMARY:**

The Drug Enforcement Administration (DEA) published a document in the *Federal Register* of January 28, 2015, concerning a notice of application for registration as a bulk manufacturer of four basic classes of controlled substances. The document inadvertently omitted two basic classes of controlled substances.

**Correction**

In the *Federal Register* of January 28, 2015, in FR Doc. 2015-01576 (80 FR 4592), on page 4592, in the second column, in the table of the second paragraph of the Supplementary Information caption, add entries for “Oripavine” and “Tapentadol” to read as follows:

| Controlled substances | Schedule |
| --- | --- |
|  |  |
| *    *    *    *    * |  |
| Oripavine (9330) | II |
| Tapentadol (9780) | II |

Dated: June 01, 2015.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.